These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

924 related items for PubMed ID: 25964525

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. MYCN-targeting miRNAs are predominantly downregulated during MYCN‑driven neuroblastoma tumor formation.
    Beckers A, Van Peer G, Carter DR, Mets E, Althoff K, Cheung BB, Schulte JH, Mestdagh P, Vandesompele J, Marshall GM, De Preter K, Speleman F.
    Oncotarget; 2015 Mar 10; 6(7):5204-16. PubMed ID: 25294817
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Vasoactive intestinal peptide decreases MYCN expression and synergizes with retinoic acid in a human MYCN-amplified neuroblastoma cell line.
    Chevrier L, Meunier AC, Cochaud S, Muller JM, Chadéneau C.
    Int J Oncol; 2008 Nov 10; 33(5):1081-9. PubMed ID: 18949372
    [Abstract] [Full Text] [Related]

  • 26. Cellular retinoic acid-binding protein II is a direct transcriptional target of MycN in neuroblastoma.
    Gupta A, Williams BR, Hanash SM, Rawwas J.
    Cancer Res; 2006 Aug 15; 66(16):8100-8. PubMed ID: 16912187
    [Abstract] [Full Text] [Related]

  • 27. Use of RNA interference to elucidate the effect of MYCN on cell cycle in neuroblastoma.
    Woo CW, Tan F, Cassano H, Lee J, Lee KC, Thiele CJ.
    Pediatr Blood Cancer; 2008 Feb 15; 50(2):208-12. PubMed ID: 17420990
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. NCYM promotes calpain-mediated Myc-nick production in human MYCN-amplified neuroblastoma cells.
    Shoji W, Suenaga Y, Kaneko Y, Islam SM, Alagu J, Yokoi S, Nio M, Nakagawara A.
    Biochem Biophys Res Commun; 2015 Jun 05; 461(3):501-6. PubMed ID: 25896758
    [Abstract] [Full Text] [Related]

  • 38. Dickkopf-1 is down-regulated by MYCN and inhibits neuroblastoma cell proliferation.
    Koppen A, Ait-Aissa R, Hopman S, Koster J, Haneveld F, Versteeg R, Valentijn LJ.
    Cancer Lett; 2007 Oct 28; 256(2):218-28. PubMed ID: 17643814
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Serial transcriptome analysis and cross-species integration identifies centromere-associated protein E as a novel neuroblastoma target.
    Balamuth NJ, Wood A, Wang Q, Jagannathan J, Mayes P, Zhang Z, Chen Z, Rappaport E, Courtright J, Pawel B, Weber B, Wooster R, Sekyere EO, Marshall GM, Maris JM.
    Cancer Res; 2010 Apr 01; 70(7):2749-58. PubMed ID: 20233875
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 47.